Asked by: Stephen Doughty (Labour (Co-op) - Cardiff South and Penarth)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, how many vaccine manufacturing facilities (a) for the production of raw materials, active ingredients, coupling and formulation and (b) for fill and finish there are in the UK; and how many of those facilities are being used for covid-19 vaccine production.
Answered by Nadhim Zahawi
We have been monitoring the requirements across the supply chain from supplier through to patients for some time. All vaccine candidates’ supply and onward deployment have clear supply chain plans across the value chain, including materials, manufacturing, transportation, storage, and distribution.
Three of the UK's seven COVID-19 vaccines are being manufactured in the UK. The Government has worked closely with the manufacturers to ensure that we have sufficient capacity secured.
The Government has also invested over £300 million in securing and scaling up the UK’s manufacturing capabilities to be able to respond to this pandemic.
Asked by: Stephen Doughty (Labour (Co-op) - Cardiff South and Penarth)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, how many bio-reactors used in vaccine production there are in the UK; and how many of those bio-reactors are being used for covid-19 vaccine production.
Answered by Nadhim Zahawi
We have been monitoring the requirements across the supply chain from supplier through to patients for some time. All vaccine candidates’ supply and onward deployment have clear supply chain plans across the value chain, including materials, manufacturing, transportation, storage, and distribution.
Three of the UK's seven COVID-19 vaccines are being manufactured in the UK. The Government has worked closely with the manufacturers to ensure that we have sufficient capacity secured.
The Government has also invested over £300 million in securing and scaling up the UK’s manufacturing capabilities to be able to respond to this pandemic.